Georgia General Assembly Establishes Life Sciences Caucus to Advance Innovation and Industry Growth
Georgia Life Sciences leads effort to establish bipartisan caucus focused on advancing the state’s growing life sciences economy
March 17, 2026, Atlanta, GA – The Georgia General Assembly has announced the formation of the Life Sciences Caucus through HR 1474, a bipartisan initiative designed to strengthen understanding of Georgia’s rapidly growing life sciences sector and support policies that drive innovation, company growth, and economic opportunity across the state.
Developed and championed by Georgia Life Sciences (GLS), the caucus will serve as a platform for legislators to engage with industry leaders, researchers, and educators to better understand the opportunities and challenges shaping biotechnology, medical technology, pharmaceuticals, and advanced biomanufacturing in Georgia.
“The life sciences industry plays a vital role in Georgia’s economy, advancing groundbreaking research, creating high-quality jobs, and improving health outcomes,” said Maria Thacker Goethe, President & CEO of Georgia Life Sciences. “The Life Sciences Caucus will provide an important forum for collaboration and dialogue as policymakers work to support an environment where innovation and companies can thrive.”
Georgia’s life sciences sector continues to expand, with companies and institutions across the state driving new discoveries, scaling manufacturing capabilities, and attracting investment. The caucus will help ensure lawmakers have access to insights and perspectives from across the ecosystem as they consider policies that impact the industry’s continued growth.
Georgia Life Sciences extends its sincere thanks to the legislators who sponsored and supported the formation of the caucus, including Senators Drew Echols, Frank Ginn, Chuck Hufstetler, Michael ‘Doc” Rhett, Shawn Still, Carden Summers, Ben Watson, and Kenya Wicks, as well as House members Matt Dubnik, John LaHood, Karen Mathiak, Ron Stephens, Brad Thomas, and Bill Yearta.
Through the Life Sciences Caucus, legislators will have opportunities to learn more about the state’s innovation ecosystem, workforce needs, and policy priorities that can help Georgia remain competitive as a national hub for life sciences research, development, and manufacturing.
About Georgia Life Sciences
Georgia Life Sciences (GLS) is the state’s leading industry organization representing biotechnology, pharmaceutical, medical device, and digital health companies, along with research institutions and other ecosystem partners. GLS works to advance Georgia’s life sciences sector by supporting innovation, advocating for policies that enable growth, and developing the workforce needed to power the industry’s future.
